Research 21 Feb 2012
Researchers at the University of Copenhagen have designed, produced and patented a new chemical compound for the possible treatment of brain damage caused by stroke. The compound binds 1,000 times more effectively to the target protein in the brain than the potential drug currently being tested on stroke victims. The results of biological tests have just been published in the renowned journal PNAS. More than 140,000 people die each year from stroke in the United States. Stroke causes the brain to release large amounts of glutamate, an activating signal compound, all at once. This...
Final results were presented from the AIM-HIGH study, a National Heart, Lung and Blood Institute (NHLBI) study. The study was designed to test whether raising HDL "good" cholesterol by adding Niaspan to simvastatin would provide an additional 25 percent reduction in cardiovascular outcomes in patients with established cardiovascular...
Industry News
Even though the use of device therapies for the treatment of heart failure, heart rhythm disturbances and atrial fibrillation has increased enormously in Europe in recent years, there still remains a fear that economic policy, and not just evidence-based therapeutic benefit, will determine access to treatments, especially at this time of financial...
Association News
Dr. Max Harry Weil, called the father of the critical care movement, died of prostate cancer at his home at age 84. The founder of the Weil Institute of Critical Care, he is credited with developing the first ICUs and introducing computerised patient monitors. "The things that we are doing right now are all because of him," said Dr....
Leader Portraits, Management, Research
Researchers at the University of Copenhagen have designed, produced and patented a new chemical compound for the possible treatment of brain damage caused by stroke. The compound binds 1,000 times more effectively to the target protein in the brain than the potential drug currently being tested on stroke victims. The results of biological tests...
Research
The European Union has some of the world's best research facilities and most accomplished researchers. Harnessing their full potential will help turn novel ideas into jobs, green growth and social progress. To facilitate this, the European Commission finances, either wholly or partially, a wide range of individual research and technology...
EU News
Measuring the levels of a natural body chemical may allow doctors to reduce the duration of antibiotic use and improve the health outcomes of critically ill patients. "Infection is a common and expensive complication of critical illness and we're trying to find ways to improve the outcomes of sick, elderly patients and, at the same time...
Management, National, Research
Conference News 19 Jan 2012
Innovative healthcare IT and medical technology solutions are one step closer to winning the coveted IT @ 2012 trophy and cash prize at the IT @ Networking Awards 2012.   Willy Heuschen, Secretary General of the European Association of Hospital Managers officially opened the event, welcoming contestants and delegates. Heuschen highlighted the increasing importance and relevance of healthcare IT and the great opportunity the IT @ Networking Awards is for decision-makers to learn about these solutions; to have access to their developers and users; and to ask questions and judge the...

Industry News

Four leading experts in the care of critically ill patients will be taking part in a symposium hosted by Kimberly-Clark Healthcare at this year's European Society of Intensive Care Medicine (ESICM) focusing on the role of oral care in helping to...
Two choices for CO2 removal – to find out more about SERVO-i NIV NAVA and PUMP ASSISTED LUNG PROTECTION visit the MAQUET booth and symposia.   I. SERVO-i NIV NAVA   NIV NAVA – How will synchrony change non-invasive...
You are most welcome to attend the lunch symposium   "Out with the old, in with the new – New therapeutic approaches in the ICU"   on Tuesday 4 October at 12:30 –14:00 in room Oslo, held during the ESICM LIVES...
The exciting field of Electrical Impedance Tomography (EIT) is progressing rapidly. With PulmoVista 500 Dräger has developed the first clinical device that can be used quickly and effectively in clinical routine.   During the ESICM 2011...
A mix of interesting topics and products will be presented and you are invited to visit the company sponsored symposia and booth during the congress.   Monday, October 3, 2011, 12:30 - 14:00, room Berlin Meet the expert: case interactive...
Nestlé Nutrition Institute Is Pleased to invite You to Their Satellite Symposium   "Nutritional Challenges in patients with prolonged ICU stay"   Monday, October 3rd * Room Athens * 12.30 - 14.00   Chairman:...
The adverse effect of right ventricular pacing on implantable cardioverter-defibrillator (ICD) patient survival is sustained long-term; however, the impact appears to be mitigated by cardiac resynchronisation therapy (CRT), based on a scientific...
Lübeck, Germany – The new PulmoVista 500 is the first EIT device (Electrical Impedance Tomography) intended for everyday clinical use by intensivists to view regional distribution of lung ventilation directly at the bedside. With up to 50...
SIRS-Lab, a molecular diagnostics company based in Jena, Germany, announced the inclusion of the first patient in a 1000-patient clinical study evaluating their molecular pathogen test VYOO. The multicenter trial, performed in 11 key centers across...
Covidien has announced the availability of the new Infinity® MCable® with Nellcor™ OxiMax™ technology as an integrated component of the Dräger Infinity Acute Care System™ in Europe. This system includes the portable...
Covidien, a global provider of healthcare products and recognised innovator in mechanical ventilation and respiratory care devices, has announced the availability in the U.S. of three new platforms for its Puritan BennettTM 840 ventilator ― the...
Covidien, a leading global provider of healthcare products and recognised innovator in mechanical ventilation and respiratory care devices, today announced that it has received the prestigious American Association for Respiratory Care (AARC)...
Pharmaceutical promotion may cause some doctors to prescribe more expensively, less appropriately and more often, according to a new study. The findings, published in the open-access journal PLoS Medicine and led by University of...
  Bilateral brain activity monitoring incorporated into patient monitors used worldwide BOULDER, CO — July 30, 2010 — Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the integration...
    First Approval of ZOLL Rectilinear Biphasic Waveform Clears Path to Resume Distribution to World’s Second Largest Defibrillator Market July 29, 2010─CHELMSFORD, MASS.–ZOLL Medical Corporation (Nasdaq GS: ZOLL), a...
  BOULDER, CO — July 1, 2010 — Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today announced the results of a study examining...
Despite current policy trends, many clinicians continue to hold positive attitudes toward gifts from and marketing interactions with pharmaceutical and device companies, according to a report in the June issue of Archives of Surgery, one of the JAMA...
Boulder, CO —February 12, 2010 – Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today announced results from a recent study...